Keywords: Imd; 3,5-dsb; 3,5-disulfobenzoate; Ac; acetone; ad; adenine; AF; acriflavine; bdc; 1,4-benzenedicarboxylate; bp4mo; N-oxide-4,4â²-bipyridine; bpdc; 4,4â²-biphenyldicarboxylate; bpe; 4,4â²-bis(4-pyridyl)ethane; bpee; 4,4â²-bipyridyl-ethylene; bpp; 1,3-bis(4
مقالات ISI Imd (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Imd; Mouse bone marrow-derived dendritic cells (BMDCs); Human monocyte-derived dendritic cells (MoDCs); TEM; JAM; JAML; DC immunotherapy; APC; antigen presenting cell; BMDC; bone marrow-derived DC; CAR; coxsackie and adenovirus receptor; CCL; chemokine ligand;
Keywords: Imd; adenocarcinoma; adnexal carcinoma; cutaneous apocrine carcinoma; signet-ring cells; ER; estrogen receptor; IMDC; intramammary ductal carcinoma; PCAC; primary cutaneous apocrine carcinoma; PR; progesterone receptor;
Keywords: Imd; Dose modification; IMDC; Outcome; RDI; Renal cell carcinoma; Second-line; Targeted therapy;
Keywords: Imd; kidney; carcinoma; renal cell; neoplasm metastasis; nomograms; prognosis; CCF; Cleveland Clinic Foundation; C-index; concordance index; ECOG; Eastern Cooperative Oncology Group; IMDC; International Metastatic Renal Cell Carcinoma Database Consortium; IRTL
Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group
Keywords: Imd; IMDC; MSKCC; Prognosis; Risk stratification; Targeted therapy;
High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation
Keywords: Imd; DC(s); dendritic cell(s); DCreg; regulatory DC; GLP; good manufacturing practice; imDC; immature DC; matDC; mature DC; PCC; pro-inflammatory cytokine cocktail; PD-(L)1; programed death (ligand)1; Human; Dendritic cells; Immune regulation; Cell therapy;
Alternaria alternata acts on human Monocyte-derived Dendritic cells to mediate Th2/Th17 polarisation
Keywords: Imd; A. alternata; Alternaria alternata; CD; cluster of differentiation; DCs; dendritic cells; FACS; fluorescence-activated cell sorting; FBS; Foetal Bovine Serum; GM-CSF; granulocyte macrophage colony stimulating factor; HLA-DR; anti-human leukocyte antigen-D
Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
Keywords: Imd; Discontinuation therapy; Early discontinuation; IMDC; Systemic treatment; VEGF-TT-intolerant patients;
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus
Keywords: Imd; carcinoma; renal cell; neoplasm metastasis; thrombosis; vena cava; inferior; mortality; CN; cytoreductive nephrectomy; IMDC; International Metastatic Renal-Cell Carcinoma Database Consortium; IVC; inferior vena cava; MDACC; M. D. Anderson Cancer Center; m
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras
Keywords: Imd; kidney neoplasms; carcinoma; renal cell; neoplasm metastasis; molecular targeted therapy; cytokines; CCI; Charlson comorbidity index; IMDC; International Metastatic Renal Cell Carcinoma Database Consortium; MSKCC; Memorial Sloan Kettering Cancer Center; O
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study
Keywords: Imd; Renal cell carcinoma; Metastasis; Targeted therapy; Outcome; Prognosis; MSKCC; IMDC; Validation;
Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings
Keywords: Imd; Renal cell carcinoma; Metastasis; Targeted therapy; Outcome; Prognosis; IMDC; Reclassification;
CR3 is the dominant phagocytotic complement receptor on human dendritic cells
Keywords: Imd; ADCC; antibody dependent cellular cytotoxicity; APC; antigen presenting cell; C3d(g); C3 d(g) fragment of C3; iC3b; inactivated complement C3b fragment; CR1; complement receptor type1; CR2; complement receptor type 2; CR3; complement receptor type 3; CR4;
REVIEWImmunodominance: A pivotal principle in host response to viral infections
Keywords: Imd; ImDc; immunodominance; ImD; immunodominant; SbD; Subdominant; Flu; Influenza A; HIV; Human immunodeficiency virus; Tg; transgenic; TCR; T cell receptor; pMHC; peptide/MHC class I complex; CTL; cytotoxic T lymphocyte; APCs; Antigen presenting cells; HLA; H
Effects of human plasma proteins on maturation of monocyte-derived dendritic cells
Keywords: Imd; DC; dendritic cells; imDC; immature DC; mDC; mature DC; CRP; C-reactive protein; LPS; lipopolysaccharide; MLR; mixed leukocyte reaction; PBMC; peripheral blood mononuclear cells; PGE2; prostaglandin E2; poly I:C; double-stranded RNA polyinosinic:polycytid